throbber
_ anish
`Medical Bulletin
`
`JOURNAL OF THE HEALTH SCIENCES
`
`No. 3. June 1999. Vol. 46. Pages 183—290
`
`DOCTOR OF MEDICAL SCIENCE
`
`lntraluminal pH of the human gastrointestinal tract. Jan Fallingborg
`
`183
`
`On the pathophysiology oflate onset non-insulin dependent diabetes mellitus. Current
`controversies and new insights. Allan Vizag
`197
`
`Left ventricular systolic function after acute myocardial infarction: prognostic im-
`portance, relation to congestive heart failure and as a target for intervention. Lars
`Kaber
`235
`
`ORIGINAL ARTICLES
`
`Gastric mucosal interleukin-8 and lL-S antibody concentrations related to prevailing
`Helicobacter pylori
`infections. A Danish-Albanian study. Ole Huugen Nielsen.
`Thomas Horn, Skercli Prifti, Peter Peic/rl, Jens Henrik Sclreibel & Ivan James Dalton
`Lindley
`249
`
`Cardiovascular effects of ocsophageal dilation under general anaesthesia. Charlotte
`Ila/m Jakobsen. Vcrner Rasmussen & Jacob Rosenberg 252
`
`Risk factors in wound infections after laparotomy in obstetrics and gynaecology.
`Isabel de. In Fuente FUnnest, Bjm'ne Stigsby & Lars lleister‘berg
`254
`
`Risk indicators of disability pension. A 15 year follow-up study. Fin Biering Suren-
`sen, Jens Luncl, Ola J Haydn/52770, Erik M. Darre, Allan Deis, Peter Kryger &
`Cecilia Flarval] Miiller
`258
`
`The Danish National Hospital Register A valuable source of data for modern health
`sciences. Tuvs Folmer/Indersen, Metre Madsen, Jorge/7 Jnrgcnsen. Lene Mellemkjwr
`& Jargon H. Olsen
`263
`
`The Danish Prevention Register A comprehensive health and socio-economic, indi-
`vidual based register. Annette Snberg Rood, Claus Juli] & Finn Kamper-Jwgen-
`sen
`269
`
`ABSTRACTS OF PILD. DISSERTATIONS. See cover page 2
`
`MEDICAL Tl-IESES AND PHD. DISSERTATIONS.
`
`288
`
`SUMMARIES
`
`Bibliotek for nger. A journal devoted to medical history, ethics, philosophy and
`clinical theory, founded in 1809.
`289
`
`
`glam
`
`
`
`
`
`
`
`
`m“no.“ mmum m «um.
`
`Published by me
`Danish Medical Association and Danish Medical Society
`with support from the Faculties ofllealth Sciences
`ofthe Universities of Copenhagen,
`Aarlrus. and ()densc. and the Danish National Board ofllcalth
`This material was emptied
`atthe NLM and ”nay be
`Euzbjett Uzifioplvright‘ Laws
`
`PROPERTY OF THE
`NATIONAL
`LIBRARY OF
`MEDICINE
`
`KVK-TECH EXHIBIT 1039
`
`KVK-TECH EXHIBIT 1039
`
`

`

`DOCTOR OF MEDICAL SCIENCE
`
`Ox
`
`lntraluminal pH of the human
`
`gastrointestinal tract
`
`Jan Fol/1'ngborg
`
`This review has been accepted as a thesis together with live previously pub—
`lished papers, by the University oanrhus, December 14. 1998, and defended
`on April 23, 1999.
`Department ofMedical (iastroenterology, Aalborg Sygehus.
`Correspondence: Jon It‘u/lingbotg, Ducbrodrevej 23. DK-9000 Aalborg,
`Official opponents: Per Bro/tech Martens-en, MD, Peter M Funch Jensen,
`MD, and Steel] Lim/A'zerJensen. professor, MD.
`
`1. INTRODUCTION
`
`The recent and increasing interest in the pH ofthe contents ofthe
`gastrointestinal tract is well founded. One reason is the development
`Ofseveral oral preparations which release the drug at a site and/or at
`a rate determined by the p11 ofthe surrounding fluid (1-10). Precise
`knowledge ofthe pII profile ofthe gut, including the interindividual
`variability, is a prerequisite for designing optimal delivery systems
`based on this concept.
`From a theoretical point ofview the intraluminal pH ofthe gut pri-
`Y
`maril
`is determined b three factors: the absorption and secretion of
`acid and base by the intestinal epithelium, the bacterial degradation
`of ingested food, and the rate oftransport ofthe intestinal contents
`through the gut.
`Determinations ofthe intraluminal pII ofthe gastrointestinal tract
`have been performed for several decades. Early studies were based
`on aspiration ofgastric or intestinal fluids, or measurements on file-
`ces. Ilowever, the development of small le-sensitive, radiotrans-
`mitting capsules has provided a method which allows pl I-determina-
`tion under almost physiological conditions.
`The aims of the investigations (11-15) presented in this review
`were as follows: to evaluate a method of determining local intralu-
`minal pI'I ofthe gut based upon the combined use ()fpl I—capsules and
`fluoroscopy; to use this method in studying the pl I-proflle ofthe gag-
`trointestinal tract in healthy human subjects and in children; to study
`the effect of various factors on this pl I-prolile.
`The present review discusses current knowledge of the intralu—
`minal intestinal pl I with special reference to data generated with pl 1-
`capsules.
`
`2. 'METIIOI)S
`
`pl'I ofthe gut is a very sensitive parameter, influenced by many kinds
`of outside impacts. A major problem in measuring gastrointestinal
`pH is, therefore, that it involves the introduction ofa tube or a trans-
`ducer into the gut ofthe subject studied, and the procedure in itself
`might induce changes in the p11 it measures. Various methods have
`been developed with the intend to minimize the physical trauma to
`the subject, thereby minimizing the possible effect ofthe procedure
`on the recorded pl I.
`
`2.1 INTUBATION TECHNIQUES
`
`Naso-intestinal intubation techniques are easily performed, but pose
`a number of limitations that can provide less than accurate results.
`For example, hypersalivation caused by the intubation may dilute the
`aspirate and thereby raise the gastric p11 due to the alkaline pH of
`saliva. Reflux through the pyloric sphincter due to nausea caused by
`the procedure may also falsely raise the gastric pl 1. Conversely, gast-
`ric fluid transported along the tube may falsely decrease the pH in
`the small intestine.
`
`2. 1.1 Aspiration technique
`Aspiration of gastric fluids through catheters has been employed for
`decades, and it has the advantage ofdireet measurement on the fluid.
`Only the proximal gastrointestinal tract is usually studied by this tech-
`
`nique, but Barbe/o et a] (16) studied the entire intestinal tract — from
`the stomach to the rectum _ of infants (aged two weeks to three
`months) by an aspiration technique using an infant Miller-Abbott tube
`with a balloon inflated with 5-8 ml air. The balloon was inflated when
`
`the tube was placed in the duodenum. The tube then passed rapidly to
`the terminal ileum, and more slowly, within 24—36 hours, through the
`colon to the rectum. The ethical aspects of performing this potential-
`ly hazardous procedure in infants are mentioned in their article.
`
`2.1.2 Dialysis bags
`A method introduced by Mumer ( 1 7), later described and utilized by
`Rune and Koster (18) involved the use ofa suitable membrane filled
`with distilled water and placed in the stomach via a connecting tube.
`Aflcr a time the contents ofthe bag were withdrawn, and the hydro-
`gen-ion content was determined. This method is useful in determin-
`ing an average pH level in the stomach, but does not reflect rapid
`changes in gastric pH.
`2. 1.3 Electrodes
`
`Intubatcd glass electrodes or antimony electrodes may be used to de-
`termine the intraluminal pH of the upper gastrointestinal
`tract.
`Electrodes have the advantage over dialysis bags and aspiration tech-
`niques that they are capable of reflecting p11 fluctuations occurring
`in the gut lumen. Furthermore, registrations can be made continu-
`ously on ambulant patients when the electrode is connected to an am-
`bulatory recording system. Savor/"no et al ( l 9) found an excellent cor-
`relation between values obtained with an intragastric pH monitoring
`equipment (Digitrapper 6000, Synetics. Sweden) and simultaneous
`gastric aspiration.
`
`2.2 TUBEI.ESS TECHNIQUES
`2. 2. 1 Chemical methods
`
`Indirect methods of determining the presence or absence of gastric
`acidity have been suggested. One method involved the use ofcationic
`exchange resins to determine the absence or presence of free hydro-
`chloric acid. The procedure depends on the dissociation ofthe resin
`by the hydrochloric acid in the stomach. The cation is absorbed and
`excreted in the urine in the presence of free acid only (20).
`Another technique involves the use of pills containing methylene
`blue wrapped in an indigestible sac tied by a catgut suture. Free acid,
`ifprescnt in the stomach, dissolves the suture and allows the release
`ofthe dye. The dye is then absorbed and excreted in the urine. Lack
`offree acid prevents the release ofthe dye. This procedure (Desmoid
`pill technique) was first devised by Salt/i in 1905 and reintroduced
`by Levere and Palmer in 1960 (21).
`Obviously, these methods are indirect, nonspecific, time consum-
`ing, and consequently of limited value.
`
`2.2.2 lt’mliotelemetrjv capsules
`In 1957 the first radiotclemetry capsule for measuring pH was in-
`vented by Jaeobscn and MacKay (22). A copolymer resin, which
`changed its dimensions with changes in p11, was used as the traits-
`ducer. The change in dimensions was transferred to an iron core mov-
`ing inside a coil, and this caused a shift in the frequency ofthe os-
`cillator in the capsule. The very slow response time ofthe transduc-
`er decreased the clinical value ofthe capsule, and there are no reports
`ofits use forcIinical investigations. In 1959 a telemetry capsule using
`an antimony electrode as transducer was developed by Ntb‘l/er (23),
`and this pI l-capsule was later referred to as the Heidelberg capsule.
`The p11 measuring cell in the Heidelberg capsule is made up of an
`annular external antimony electrode which is in contact with the sur-
`rounding fluid, and an internal AgCl electrode separated by a semi-
`permeable membrane (24). p11 changes the potential difl‘erence be-
`tween the electrodes, which in turn control the frequency ofthe ra-
`dio transmitter. The tnain disadvantages with the early type ofthis
`capsule were the short life and serious drift problems, caused by an
`oxidation ofthe antimony electrode in the presence ofintestinal fluids
`(25, 26). The limitations of this capsule made it suitable only for
`studies of the stomach and small intestine, although Aral/(mi et (ll
`(27) “50d It in a study ofthe entire gastrointestinal tract in human vol-
`
`I)anish Medical Bulletin
`
`Th is material was {spied
`at the N LM 3 nel may be
`Subject: US {Mayright Laws
`
`I 83
`
`

`

`unteers and patients. The study subjects initially passed a tube
`throughout the gastrointestinal canal and then the capsule was pulled
`through. Later improvement ofthe capsule has made it a more reli-
`able tool of pH measurement, but the accuracy ofthe capsule is still
`only about 0.5 pll units (28, 29), and the lifetime is only 22 h (2‘)).
`ln 1965-6 two pll capsules using glass electrodes were designed: a
`Japanese capsule (30), which, however, has never later been men-
`tioned in clinical studies, and a capsule manufactured by Remote
`Control Systems Ltd, London, England, referred to in the present pa-
`per as the RC8 capsule (31). The main problem with the p11 glass
`electrode is the high impedance. The electrode must also be sealed
`to prevent development of leakage paths, which shunt the potential
`produced by the transducer. The early RCS capsule depended on
`epoxy resins to form the seal, but moisture caused a gradual deteri-
`oration in the p11 response and a short lifetime for these capsules.
`Later a covering layer of glass was added which increased the life-
`time ofthe capsule to more than one month (32). The Japanese cap-
`sule and the RC3 capsules respond to alterations in pH by changing
`the transmission frequency ofthe transmitter in the capsule. The RCS
`capsule uses a PM oscillator with a transmission frequency of ap-
`proximately 400 kHz, whereas the transmission frequency of the
`Japanese capsule is 1.9 MHz. The electrical circuits ofthe two cap-
`sules share many aspects. A glass pl l—electrode is in contact with the
`surrounding fluid and an Ag/AgCl reference electrode is situated in
`the battery cap ofthe capsule. Variation in potential difference be-
`tween the pH-electrode and the reference electrode causes a change
`in the capacitance ofa reverse biased diode (varicap), with a corres-
`ponding change in output frequency (32, 33). The response in trans-
`mission frequency of the RC8 capsule is linear in the interval be-
`tween pll l and p11 9 (33, 34).
`A small number ofother types ofradiotelemetry pl'l-capsules have
`been developed but the Heidelberg capsule and the RCS capsule (Fig.
`1) are those most frequently used in published clinical studies.
`
`2.2.2.1 Methodological problems using the pll—capsule
`a. Localization of the capsule
`When an untethered capsule is ingested, it travels freely throughout
`the gastrointestinal canal, and a crucial point is how to determine the
`precise location ofthe capsule in the gut at the time ofpll measure-
`ment. The location which poses most problems is the ileo-caecal re-
`gion. By using a radio directional antenna to determine the position
`at which the maximum signal strength oftransmission is received,
`the regional localization ofthe capsule can be made with an accur-
`acy 015 cm (35, 36), but it is not possible to determine by this method
`whether it
`is located in the caecum or in the terminal
`ileum.
`
`Fluoroscopy enables a more precise localization, but if the gas con-
`tent ofthc colon is sparse, the distinction between the terminal ileum
`
`
`
`Fig. l. Thepll-sensi/ivc, rmliote/emetrycapsule (RCS capsule). Dimensions:
`diameter 7 mm. lung/1! 27 nun (a male/1 is shown/or comparison of'size).
`
`and the caecum may be diflicult. The use ofradiopaquc contrast (15)
`or gamma scintigraphy technique (35) to visualize the region may be
`an advantage. Repeated fluoroscopic investigations with short inter-
`vals in between can be ofgreat help, especially when sudden changes
`in pll occur. It is often observed that a capsule located in the ileocae-
`cal region has dropped 5 to 10 cm dowawards (i.e. into the caecum)
`between two fluoroscopic investigations, and usually this is associat-
`ed with a sharp decrease in pl 1. However, it must be recognized that
`even with the use of frequent fluoroscopic determinations ofthe loca—
`tion ofthe capsule, and even with the assistance ofa skilled radiolo-
`gist, a small number ofthe determinations may be incorrect. The ma-
`jor problem with repeated fluoroscopic investigations is the radiation
`exposure. The length of radiation must be kept as shott as possible,
`and this may best be achieved with the collaboration ofa radiologist.
`An improved method of localisation of the pl-l-capsule in the
`caecum was used by Sosa/ti et a] ( 37). A contrast colonogram was ob—
`tained before the investigation. The receiver was connected to a com-
`puter-assisted analysing system, and when pH sharply decreased by
`1 pH unit/min or more (i.e. when the capsule entered the caecum) the
`system generated a beeping sound. A plain abdominal x—ray was per—
`formed and superimposed on the previously performed contrast
`colonogram, and the presence ofthe capsule in the caecum could be
`verified. Thereafter, the position ofthe capsule in the colon was de—
`termined at 2-h intervals with a radio directional antenna. In two pa—
`tients a plain x-ray film was taken after a measurement of pH by the
`antenna, and the position ofthe capsulejudgcd by the antenna method
`was correct. The study demonstrates, that ifthe configuration of the
`colon is known, the localization ofthe capsule can be reasonably well
`determined by the use ofa radio directional antenna. The method is
`elegant and the computer-assisted analysing system could be ofgrcat
`help in monitoring pH in the colon of patients with chronic inflam-
`matory bowel disease, where very low pH values have been report—
`ed (14). However, a contrast colonogram may not be available in all
`patients, and the topographic position ofthe colon may be slightly
`influenced by the position (upright or succumb) ofthe patient.
`
`b. Gastrointestinal transit of the capsule
`When the capsule is ingested, it is freely mobile and its localization
`in the gut will be determined by the propulsion movements of the
`gastrointestinal myometrium. The gastric emptying oflarge (>1 mm)
`particles is dependent on the interdigestivc migrating myoelectric
`complex (lMMC) (38, 39). When solid food is present in the stem-
`ach it contracts 3-4 times per minute, and the pylorus is partially
`opened, allowing liquid and small particles to pass. When the stom—
`ach is empty of food, several phases of myoelectric activity occur,
`ending with the phase 111, the lMMC, which consists ofan opening
`ofthe pylorus and of3-4 peristaltic contractions from the stomach to
`the caecum, allowing emptying ofthe stomach of undigested mate—
`rial (“the housekeeper wave”) (40, 41). This cyclic pattern ofevents
`occurs on average every two hours in fasting humans, but it is inter—
`rupted when food is ingested. The gastric residence time (GRT) of
`the pH-capsule therefore depends on the dietary state ofthe subject.
`In a fasting subject the average GRT ofthe capsule is 1.1 to 1.9 hours
`(11-13, 29, 42). A small liquid meal prolongs the mean GRT to 2.6
`hours, and frequent intakes of food increases it to more than 14.5
`
`hours (42). This important aspect concerning the gastric emptying
`must be taken into account when sustained release tablets with coat—
`
`ings resistant to acid are prescribed. lfsuch tablets are taken together
`with meals, they will remain in the stomach until it is empty of food.
`and ifthe subject eats frequent meals during the day the stomach will
`not be empty before sometime during the night. Consequently, it is
`of no relevance to take such tablets two or more times daily, while
`all or most ofthe tablets will remain in the stomach the entire day
`and later all are emptied into the duodenum sometime during the fol-
`lowing night (43, 44).
`The small intestinal transit time (SITT) of the capsule in adults
`varies from 2.8 to more than 14 hours (1 1, 45) and average values of
`5.7 to 8 hours are reported (1 l, 35). The capsule travels rapidly from
`
`184
`
`This mate-rial wasteopiael
`atthe NLMand may be
`Subject UEEopy‘right Laws
`
`V0146 No. 3/Junc 1999
`
`1w
`
`

`

`the duodenum to the distal part ofthe small intestine, and about two-
`thirds ofthe SlTT is spent in the part ofthe small intestine that is lo-
`cated in the lower right abdominal quadrant (1 1). This slow transit
`through the distal small intestine is in accordance with the observa-
`tion of Ker/in & Phillips (46), who found that the lMMC travels
`through the small intestine with a velocity that decreases from 4.7
`cm/min in thejejunum to 0.9 cm/min in the terminal ileum. Ingestion
`offood also interrupts the lMMC ofthe small intestine (46). In child-
`ren, the median SlTT was almost identical
`to that of adults (7.5
`hours), and for three quarters ofthat time the capsule is located in the
`distal small
`intestine (13). The rapid transit through the jejunum
`makes it difficult to study the p11 ofthis part ofthe gut with a freely
`moving pl 1 capsule. In a study using capsules tethered with a 2 metres
`long nylon line it was possible to obtain pH measurements from the
`proximal part ofthejejunum (34). However, the line slowed the tran-
`sit ofthe capsule considerably, so it was not possible to measure pll
`in the more distal parts ofthe small intestine in that study.
`The colonic transit time ofthe capsule is about 17.5 hours (equal
`in adults and children), but it varies widely from less than 10 hours
`to l 12 hours, and the capsule is located in the caecum for about half
`ofthis time (1 1, 13). The colonic transit time tends to be longer in fe-
`males than in males (1 1).
`The day-to-day variation ofthe regional transit times is consider-
`able, and in a study ofthe day-to-day variation in 13 healthy subjects
`the variation coefiicients ofthe CRT and colonic transit time were
`about one (1 l). The SlTT was more consistent and the variation eo-
`elfteient was 0.40 (11).
`
`e. Linearity li'equency drift, precision and accuracy
`The response ofthe transmission frequency to alterations in p11 was
`tested by Me/a’rzmz er [I] (33) and by Fallingborg er a] (34) concern-
`ing the RC8 capsule, and was found to be linear within the interval
`between p11 1 and pH 9. The response ofthe Heidelberg capsule has
`also been found to be linear in the interval between pH 2 and 7, but
`above and below this interval the frequency response decreased (47).
`Calibrations ofthe capsules before and after a study will secure their
`accuracy at the calibration levels at the beginning and at the end of
`the study. As previously mentioned, the main problem with the ear-
`ly types of radiotelemetry capsules, and especially the Heidelberg
`capsule, was the frequency drift. This was mainly due to an oxida-
`tion ofthe antimony electrode in the presence ofintcstinal fluids. The
`problem was less with capsules using glass electrodes, and in the
`study of Fallingborg at a] (1 1), using the RC8 capsule, a maximal
`drift of 0.5 pH units was registered, with the exception ofone sub-
`ject in whom the increased drift was due to a defective reference cap.
`The frequency drift may affect both the accuracy (zero-point drift)
`and the precision (change ofthe slope ofthe response-curve) ofthe
`pll capsule, but, assuming that the drift develops with a constant rate
`during the study, a correction ofthe frequency drift can be performed
`after recalibration ofthe recovered capsule (14):
`
`
`
`
`0.1111('1‘(.)—0p119('ro)- ' en '10
`
`xtow 1 nan-0m 1 memo-Opt |9(To)‘op| [9(Te11d))
`
`
`
`
`
`o,,,,.,(,.,,,d,:
`
`Corrected pll value, measured at T)(
`le'x
`Time ofpre—calibration
`1;:
`Time of post-calibration
`Tend:
`Time of p11 measurement
`TX:
`Transmission frequency measured at time Tx
`61),:
`611111111113 Transmission frequency ofthe capsule at pH 1 , 37°C, measured
`at pro-calibration
`0mm 1WD: Transmission frequency ofthe capsule at pH], 37°C, measured
`at post-calibration
`Op] Wt 1b,: Transmission frequency ofthe capsule at p119, 37°C, measured
`at prc-calibration
`'l'ransmission frequency ofthe capsule at p119, 37°C, measured
`at post-calibration
`
`
`The accuracy ofthe RCS capsule has been evaluated by Meldrum et
`a] (33) and by Fullingbmg cf (11 (12) by comparing p11 in faeces and
`ileostomy output, measured by the RC8 capsules and with a pl l-meter
`(Radiometer, Copenhagen), respectively. The maximal difference be-
`tween pl 1 values measured with the two methods was 0.2 and 0.3 pH
`units, respectively, in the two studies.
`
`d. Frequency ofmeasurements
`In some studies pH was automatically registered 6 or 60 times per
`tninute and stored in a recording system, whereas in other studies in-
`cluding those made by the author of this thesis the measurements
`were performed manually with intervals of 10 minutes or more. The
`frequent, automatic recording method has several advantages: it can
`be used in outpatients, it is able to demonstrate pH-changes of short
`duration, and measurements can also be performed while the person
`sleep. The major disadvantages ofthis system are that only one sub-
`ject can be studied at a time for each recording system, and that meas-
`urements obtained during periods with low signal or signal loss may
`be incorrect. The importance ofa high signal quality was emphazised
`by Press e! a/ (48) who observed that artificial low pH values could
`be registered when the recorder indicated poor signal quality. The
`main advantage with manual recording is that an optimal signal qual-
`ity can be secured at each recording, and that more than one subject
`can be studied at the same time. The disadvantages are that p11-
`changes that occur between measurements will not be discovered,
`and that the method cannot be used in outpatients.
`
`3. GASTROINTESTINALpII IN NORMAL
`HUMAN SUBJECTS
`
`Since 1964 a number ofstudies on human gastrointestinal p11 using
`pll-sensitive capsules have been published. The majority ofthese
`studies deal with measurements of gastric residence time or meas-
`urements ofthe acid secretory capacity ofthe stomach, and, there-
`fore, only contain pH measurcments from the stomach and the duo-
`denum (Table 1). However, a numberofstudies also report pll meas-
`urements from tnore distal parts of the gut (Table 2). Many papers
`contain data obtained from normal human subjects, but in several of
`
`
`
`Fig. 2. Median (broken line) and interquarli/e range ofgastrointestinal pl!
`lileuszn‘ed in 33 lieu/[Int adult volunteers (11).
`
`Danish Medical Bulletin
`
`This material wast-{spied
`atthe NLM and may be
`Subject Ui{1e~py‘right Laws
`
`185
`
`

`

`
`
`‘ m I/
`'
`Published stud/es (
`'
`()ch’fillm.
`[/0]. ill [/16 ll“
`
`Table 1
`aclr (1)76
`
`1e
`
`.
`my (Jpll-scnsilivc. I'm/iali'cmsmfiling capsules. [/7 viti'o studies and human studies confined to nwasurenicms In the xlonr
`
`Subjects
`Type irfeapstrle
`
`itci‘crcnu:
`
`—
`—
`30 duodenal ulcer patients
`—
`30 normal subjects and patients
`50 normal subjects (+ antacids)
`—
`
`prototype, 400 k1 lz
`.......................
`M «Km 1957 (22) ........................ prototype, 1.9 M1 12
`JW’b‘O’Z 8:“ 3) ...............
`(l leidelbcrg)
`N51,” 1 )5
`H
`.................... Heidelberg
`-
`-
`-
`.
`.
`,
`1‘: ”liters, 1964 (25) .
`..................... Heidelberg
`CHEW/f 41/1 1965 (47) ......................... Heidelberg
`Stein/WALES
`.
`1 1965 (49) ........................... Heidelberg
`”WSW AV lat/0’ 9(5 (50) """"""""""
`rolot
`e 400 kl 12
`Ran/l & Nil/cl: l106’5 (3 1) ................................
`pRCS)yp .
`20 duodenal ulcer patients
`”mm” & (I).
`.................. Heidelberg
`l8 atients with d strophia rnyotonica
`)
`‘ 6 51) ............................ Heidelber’
`46 ilyspectic patiei/its (+ Spasrno-Nervogastrol®)
`Stu/WW); :i’llll'9lééfil5él
`................. Heidelber:
`-
`'
`'
`'
`'
`'
`'
`'
`I
`i
`I
`j
`i
`I
`i
`i
`12 patients (+ mctocloprainide)
`.
`11:11'1-[1/27-‘196763.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`-
`-
`-
`.................... Heidelberg
`(Eases
`.
`Stijl/lgé’: 1967 (54). .
`.5.
`.
`.
`.
`.
`i
`i
`j
`Z :1 ....................... Heidelberg
`'t' ‘ 1‘
`1* ..
`'l
`)
`77
`'
`Cases
`MUiWM ‘1’ “l' [967 (5 ) ............................... Heidelberg
`24 normal subjects, .2 duodena ti cet pa ten s
`Ki'lllcr, 1967 (5(7) »
`-
`-
`'
`' 1969(26) .......................... Heidelberg
`26 patients
`A‘vmici‘ycm & Bing/mm.”4
`........................... Heidelberg
`.1
`,
`2‘) patients
`.
`_
`‘
`.
`,
`)lirbml’gh a! (Il. 1969 (- ) ............................. Heidelberg
`45 patients with anaemia (21 With pernicious anaemia)
`Dev/ile er al, 1969 (57) ............................. Herdelbei‘g
`1 normal subject-and 29 patients
`.
`.
`iVil/iwiixwl L” "1' 1969 (58) ............................ Heidelberg
`23 dyspeptic patients (+ acetysalicylrc actd)
`Stuck, 1969 (59) ......... (1)1. ‘
`' ........................ Heidelberg
`13 normal subjects (+ antactds)
`Russell & Goldberg. 197? ( ) 61) ......................... Heidelberg
`27 dyspeptic patients
`Gall/3W” & I’M/"mm I )707(
`......................... Heidelberg
`Cases
`.
`Andres & Bil7glm’77- 1970 (6') ...........................
`Prototype, [-9 MHZ
`10 duodenal ulcer patients
`KIWI! C” "L '97] (63) ................................ Heidelberg
`.
`37 healthy children
`-/(3/7a”’7"3-"”" “1 ”l‘ 1973’ (64) ............................ Heidelberg
`16 normal subjects (+ antacids)
`Sfl‘ldlikom' 1973 (65) """(i
`i
`. (jo) ...................... Heidelberg
`23 normal subjects (transeranial electrothcrapy)
`Mill/Ge & Al’lllw'll/icllunl'
`l )75 (
`..................... Heidelberg
`1 18 normal subjects (7L antacids)
`Kuiiei' e! (Il, 1975 (67) .................................. Heidelberg
`10 normal subjects (+ antacids)
`”WC/"’1’" 6’ "l' 1975 (68) ............................. Heidelberg
`
`5 normal subjects (+ insulin :: bromazepam)
`EkWWC‘I‘Q ”mam 1975 (69) ......................... Heidelberg
`4 normal subjects + 19 peptic ulcer patients
`SIM/7"" & Starker. 1975 (70) ..............................
`2 prototypes
`12 normal subjects
`Misti/ii & meil, 1976 (71) ......................... Hcidclbcrg
`147 patients
`Rifle/16119 Erni, 1977 (72) ----~*""""”":: .......... Heidelberg
`11 normal subjects (+ sucralfatc / + antacids)
`[lei’lkel' 1980 (73) ................................ Heidelberg
`24 normal subjects, 31 duodenal ulcer patients.
`McGniw e! Ill. 198' (74)19é; (75) iiiiiiiiiiiiiiiiii Heidelberg
`10 normal subjects (+ antacids)
`U1’5i’"1" & Keyrilulncii.
`J
`iiiiiiiiiiiiiiiiiiiiiiiii
`llcidelber v
`16 normal subjects
`[MIC/1810,, 1984 (76) ....................................
`[Icidelbcrz
`1 patient with Crohn’s disease
`111(1jcivei‘i'ui7 er [I], 1985 (42) .............................
`[Icidclberg
`4 duodenal ulcer patients
`Faegcnbiirg er zil, 1985 (77) ,
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`. .... RCS
`8 normal men (+ procainamide)
`Reynolds 0! ul. 1986 (78) -
`'
`-
`'
`'
`‘
`'
`’
`‘
`'
`'
`i
`'
`I
`'
`i
`i
`i
`i
`i
`i
`I
`i
`i
`I
`j
`..... Heidelberg
`8 normal subjects (+ aspirin)
`Rocci cl (Il. 1987 (70) .................................
`Ileidelbcrg
`45 normal subjects
`lllly'uveriun 61 (II, 1987 (80) ............................
`[[eidclbcrg
`10 normal subjects
`Mnjtiverluii er Lil, 1988 (81) ..............................
`”ciddbcrg
`12 normal men (i ranitidine)
`Ewe ctul. 1989 (82) 'i'”H'HUHHHHHH-im.:: .... Heidelberg
`:liealtlryl/ mlcn (+ diclofenac sodium)
`IciiI/(yluwfiljflfijdljtlfgo (83)
`'
`i
`'
`I
`i
`i
`.......... Heidelberg
`norma Stnjects
`7cm 0 u.
`............... lleidclbei"
`6 normal males (+ ketoconazole :t ciinetidine 2t sucrall‘ate)
`Maiziveriun ci a], 1991 (29) -
`~
`'
`'
`‘
`'
`i
`j
`I
`..... Heidelberg
`'
`'
`'
`i
`'
`'
`l
`'
`i
`i
`i
`i
`i
`i
`6 normal subjects (+ glutamic acid i ranitidine)
`”SCI-’81“ 0’ "l' 1991 (85)'
`'
`i
`'
`'
`'
`'
`'
`j
`'
`I
`j
`i
`i
`j
`i
`j
`i
`i
`j
`j
`i
`j H ........ Heidelberg
`12 normal subjects (+ theophylline i: ranitidine)
`Kim/2p at al. 1991 (89) -
`-
`'
`’
`'
`'
`'
`'
`'
`'
`'
`'
`'
`'
`'
`I
`i
`j
`i
`j
`I
`i
`i
`......... Heidelberg
`12 normal subjects (+ enoxacin i ranitidinc/pentagastrin)
`Bel/ac]: et ul, 1991 (87) .................................. Heidelberg
`79 healthy elderly subjects
`Lehmch at a], 1:))2(88) .
`i
`i
`i
`j
`I
`i
`i
`I
`i
`j
`i
`i
`I
`i
`i
`i
`i
`i
`i
`i ............ Heidelberg
`8 normal subjects, 7 achlorhydric subjects. (+ theophylline)
`RUSH)” el ul, 1‘? )3 £8 )) .................................. Heidelberg
`18 normal subjects (+ diclofenac i ranitidine)
`New]. 61 “1' 1(1)} (()0) iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii Heidelberg
`24 normal subjects (+ l1uconazole or itraconazole)
`imam Li, “A I ))3/()119)9.4. 97 9;) I
`i
`i
`i
`i
`j
`I
`i
`j
`............. Heidelberg
`11 healthy subjects (> 64 years, + dipyridamole i famotidine)
`£1,752,221; [till/fl" 1869,4794)
`( A"
`i
`j
`I
`.................. Heidelberg
`12 normal subjects (+ l1ucona7o1e i omeprazole)
`,
`.
`""""""""""" Heidelberg
`10
`‘n' I Sub' ~cts (+ 2':
`~
`r
`t
`)
`'i
`)
`'1ni i.
`i" r
`.
`[Mmmnmm 0’ "l‘ 1994(95) """"""""""""""
`ii rd in
`"9” 1“ l
`'1‘- ‘
`' 1C 390 a ctr l “C ( X" b
`amo K1119)
`Henderson er til, 1995 (96) ...............................
`Ll
`‘- 7‘J‘l:
`5 norma’ sir 7kale .
`(Ironing & Bei‘iiigen. 1996 (97) ........................... Heidelberg
`
`'3Lewis & Neuron, 1997 (98) ............................... 13 normal subjects
`
`
`these articles the results from the healthy subjects and those obtained
`from patients are not separated. Therefore, only a limited number of
`these study results can be used to describe the pH-profile of normal
`humans (Table 3). On the basis of these selected studies, supple-
`mented with results from studies using other methods, a picture of
`the pH profile ofthe normal gastrointestinal tract can be made.
`However, it should be kept in mind that a normal colonic pH-proiilc
`may vary in different ethnic and cultural groups and in different parts
`ofthe world, because dietary habits may affect the intraluminal p11
`(see Chapter 7.1).
`tract, based on
`The pl l-profile of the normal gastrointestinal
`measurements obtained with the RC8 capsule, is shown in Fig. 2
`(11).
`
`3.1 STOMACH
`
`The acid environment in the lumen ofthe stomach is attained by pro~
`ton secretion from the parietal cells in the corporal mucosa. 1n a fast—
`ing subject, the p11 ofthe gastric fluid ranges from 1 to 3.5 (11, 27.
`30, 89), but ingestion of food, milk, or antacids may shortly increase
`p11 to about 7 (24, 33, 89, 110).
`
`3.2 DUODENUM
`
`Due to the rapid transit ofthe untcthered pl 1 capsule through the duo—
`denum, only a few recordings can be performed in this region using
`this method. Thus, results obtained with tubes", glass electrodes, or
`tethered capsules must be regarded as the most reliable. in the duo-
`denum, the p11 ofthc intestinal fluid is changed from acid to neutral
`
`186
`
`This mate-rial wastap
`i“
`at: the NLM arid may be
`Subjeet‘ LIE {iupyright‘ Laws
`
`Vol 46 No. 3/JuitL‘ 1900
`
`

`

`Table 2. Clinical .s‘lIlt/ies 0n lmmun grist/‘0intestinal [)1] [Measured with [III-sensitive. I‘m/iotrunsmfiling capsules. Slut/[es containing pll meustI/‘emenrs in [he
`small intestine and/or in [lie colon.
`
`References
`'1) pe ol‘capsulc
`Region
`Subjects
`_____________—_____—_.—___—_——_
`
`1 normal subject and 16 patients (secretin)
`jejunum
`Heidelberg
`ll’atson & l’umn, 1965 (49)
`20 normal subjects and patients
`Total Gl-tract
`prototype, 1.9 MHZ
`Kitagawa e1 0/, 1966 (30)
`9 normal subjects, 10 patients
`Total Gl-tract
`Heidelberg
`Aral/(mi e] a], 1967 (27)
`10 normal subjects, 21 patients
`jejunum
`Heidelberg
`Maxwell e1 ul,

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket